EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Changes in sales of medically important antimicrobials for use in livestock animals in Canada following the 2018 federal policy mandating veterinarian prescription

Fiona Emdin iD, E Jane Parmley, Kevin A Brown iD, Angelina L Bosman, Carolee A Carson, Valerie Leung iD, Bradley J Langford iD, Kevin L Schwartz iD, Nick Daneman iD

Journal of Antimicrobial Chemotherapy · 03.11.2026 · 81 (12)

DOI: 10.1093/jac/dkag385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 13.11.2026. Verfasst von Fiona Emdin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Livestock, Commerce, Veterinarians, Anti-Infective Agents. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial resistance (AMR) threatens human and animal health globally, and antimicrobial use in food-animal production is increasing. On 1 December 2018, Canada implemented federal policies requiring medically important antimicrobials (MIAs) for veterinary use to be sold by prescription only and removed growth-promotion claims from labels. We evaluated whether these policy changes were associated with changes in livestock antimicrobial sales.

Methods

We conducted a cross-sectional study evaluating annual Canadian livestock antimicrobial sales before (2018) and after (2019–2023) policy implementation. The primary outcome was annual sales of MIAs standardized as mg/kg biomass. Negative binomial regression models estimated associations between the policy and antimicrobial sales. A secondary difference-in-differences model assessed route-specific effects using injectable products as a control group because these products were already prescription-only and not labelled for growth promotion. Secondary regression models evaluated antimicrobial class, province, species, and Health Canada importance in the human medicine category.

Results

Mean national MIA sales decreased by 11% between 2018 and 2019–2023. However, federal policy changes were not associated with a significant reduction in overall antimicrobial sales [incidence rate ratio (IRR) 0.89, 95% CI 0.29–2.68; P = 0.83]. No significant effects were identified in route-specific, antimicrobial class, province-level, or species-level analyses. The difference-in-differences analysis also showed no significant policy effect (IRR 0.89, 95% CI 0.06–12.9; P = 0.93).

Conclusions

Although antimicrobial sales declined overall, we found no detectable association between Canada’s 2018 veterinary policy changes and livestock antimicrobial sales. However, the analysis had limited statistical power, meaning that smaller but potentially meaningful changes in antimicrobial sales may have gone undetected. Continued evaluation of interventions is needed to identify strategies to reduce antimicrobial use and mitigate AMR in agriculture.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LivestockCommerceVeterinariansAnti-Infective AgentsAnti-Bacterial AgentsDrug PrescriptionsVeterinary DrugsAnimalsCanadaCross-Sectional StudiesHumans

Substanzen

Anti-Infective AgentsAnti-Bacterial AgentsVeterinary Drugs

Autor:innen und Institutionen

  • Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada.
  • Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Global Strategy Lab, York University, Toronto, Ontario, Canada.
  • Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
  • Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Centre for Foodborne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, Ontario, Canada.

ORCID-Profile: Fiona Emdin, Kevin A Brown, Valerie Leung, Bradley J Langford, Kevin L Schwartz, Nick Daneman

Förderung

  • Canadian Institutes of Health Research (CIHR)

Zitieren

APA

Emdin, F., Parmley, E. J., Brown, K. A., Bosman, A. L., Carson, C. A., Leung, V., Langford, B. J., Schwartz, K. L., & Daneman, N. (2026). Changes in sales of medically important antimicrobials for use in livestock animals in Canada following the 2018 federal policy mandating veterinarian prescription. Journal of Antimicrobial Chemotherapy, 81(12). https://doi.org/10.1093/jac/dkag385

Vancouver

Emdin F, Parmley EJ, Brown KA, Bosman AL, Carson CA, Leung V, et al. Changes in sales of medically important antimicrobials for use in livestock animals in Canada following the 2018 federal policy mandating veterinarian prescription. Journal of Antimicrobial Chemotherapy. 2026;81(12). doi:10.1093/jac/dkag385

BibTeX
@article{Emdin2026,
  author = {Emdin, Fiona and Parmley, E Jane and Brown, Kevin A and Bosman, Angelina L and Carson, Carolee A and Leung, Valerie and Langford, Bradley J and Schwartz, Kevin L and Daneman, Nick},
  title = {Changes in sales of medically important antimicrobials for use in livestock animals in Canada following the 2018 federal policy mandating veterinarian prescription},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {12},
  doi = {10.1093/jac/dkag385}
}
Kostenlos starten →